| Literature DB >> 30011756 |
Michael A Borger1, Paul W M Fedak2, Elizabeth H Stephens3, Thomas G Gleason4, Evaldas Girdauskas5, John S Ikonomidis6, Ali Khoynezhad7, Samuel C Siu8, Subodh Verma9, Michael D Hope10, Duke E Cameron11, Donald F Hammer12, Joseph S Coselli13, Marc R Moon14, Thoralf M Sundt15, Alex J Barker16, Michael Markl17, Alessandro Della Corte18, Hector I Michelena19, John A Elefteriades20.
Abstract
Bicuspid aortic valve disease is a common congenital cardiac disorder, being present in 1% to 2% of the general population. Associated aortopathy is a common finding in patients with bicuspid aortic valve disease, with thoracic aortic dilation noted in approximately 40% of patients in referral centers. Several previous consensus statements and guidelines have addressed the management of bicuspid aortic valve-associated aortopathy, but none focused entirely on this disease process. The current document is an executive summary of "The American Association for Thoracic Surgery Guidelines on Bicuspid Aortic Valve-Related Aortopathy." All major aspects of bicuspid aortic valve aortopathy, including natural history, phenotypic expression, histology and molecular pathomechanisms, imaging, indications for surgery, surveillance, and follow-up, and recommendations for future research are contained within these guidelines. The current executive summary serves as a condensed version of the guidelines to provide clinicians with a current and comprehensive review of bicuspid aortic valve aortopathy and to guide the daily management of these complex patients.Entities:
Mesh:
Year: 2018 PMID: 30011756 PMCID: PMC6384009 DOI: 10.1016/j.jtcvs.2017.10.161
Source DB: PubMed Journal: J Thorac Cardiovasc Surg ISSN: 0022-5223 Impact factor: 5.209